Interestingly, in contrast to the outcome of HIF signaling pathway activation observed after IDH mutation, studies suggest that tumor cells may release D-2HG into the tumor microenvironment, triggering instability of HIF-1α in immune cells (regulatory T cells and Th17 cells) of the immune microenvironment (102). Here, IDH1 is linked to neoplasm.